Skip to main content

Table 3 Preoperative laboratory data

From: Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor

 

Non (n = 704)

Early (n = 208)

Late (n = 155)

p value

WBC

6.38

6.35

6.26

0.818

Hb

13.43

13.2

13.4

0.295

Plt

222.8

216.1

223.0

0.531

Seg. Neutrophil

57.5

59.1

56.2

0.111

Lymphocyte

30.9

29.3

32.2

0.088

ANC

3741

3774

3463

0.233

NLR

2.16

2.76

1.97

0.005

ESR

20.9

24.3

21.6

0.431

CRP

0.339

0.338

0.309

0.973

Urine cytology

 Negative

471 (82.2)

127 (77.4)

108 (86.4)

0.254

 Atypical

96 (16.8)

33 (20.1)

15 (12.0)

 

 Malignant

6 (1.0)

4 (2.4)

2 (1.6)

 

Urine WBC

 0

453 (79.5)

124 (82.1)

105 (82.7)

0.854

 1 + 2 + 

98 (17.2)

26 (17.2)

20 (15.7)

 

 3 + 

19 (3.3)

5 (3.3)

2 (1.6)

 

Urine RBC

  < 5

399 (66.5)

98 (58.7)

98 (73.1)

0.055

  < 20

73 (12.2)

27 (16.2)

9 (6.7)

 

  < 50

31 (5.2)

8 (4.8)

10 (7.5)

 

  >  = 50

97 (16.2)

34 (20.4)

17 (12.7)

 
  1. WBC white blood cell, Hb hemoglobin, Plt platelet, Seg. Neurophil segmented neutrophil, ANC absolute neutrophil count, NLR neutrophil-to-lymphocyte ratio, ESR erythrocyte sedimentation rate, CRP C-reactive protein, RBC red blood cell